ELEVATED SOLUBLE TNF-RECEPTOR-P55 AND TNF-RECEPTOR-P75 LEVEL IN CHRONIC HEPATITIS-C VIRUS-INFECTION

被引：0
|
作者：
KALLINOWSKI, B
GALLATI, H
THEILMANN, L
SINGER, MV
ROSSOL, S
机构：
[1] DEPT GASTROENTEROL,HEIDELBERG,GERMANY
[2] PHARM RES NEW TECHNOL,BASEL,SWITZERLAND
来源：
HEPATOLOGY | 1993年 / 18卷 / 04期
关键词：
D O I：
10.1016/0270-9139(93)91855-M
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A82 / A82
页数：1
相关论文
共 50 条
  • [41] Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both P55 and P75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures
    Williams, LM
    Gibbons, DL
    Gearing, A
    Maini, RN
    Feldmann, M
    Brennan, FM
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12): : 2833 - 2841
  • [42] Correlation of soluble interleukin-2 receptor (IL2-R) and tumor necrosis factor & receptor (TNF & R) levels with severity of chronic hepatitis-C liver injury
    Menessy, A
    Aref, S
    JOURNAL OF HEPATOLOGY, 2000, 32 : 196 - 196
  • [43] Tumor necrosis factor alpha (TNFα) and its soluble receptor p75 (sTNF-R p75) in familial combined hyperlipidemia (FCHL)
    Cavallo, MG
    Montali, A
    Monetini, L
    Valente, L
    Mariani, P
    Bifolco, M
    Sirinian, MI
    Antonini, TM
    Fioretti, F
    Campagna, F
    Verna, R
    Arca, M
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2005, 15 (04) : 262 - 269
  • [44] Recent Advances in Anti-Tumour Necrosis Factor (TNF) Therapy in Rheumatoid ArthritisFocus on the Soluble TNF Receptor p75 Fusion Protein, Etanercept
    Larry W. Moreland
    BioDrugs, 1999, 11 : 201 - 210
  • [45] Upregulation of the p75 but not the p55 TNF-α receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice
    Ortiz, LA
    Lasky, J
    Lungarella, G
    Cavarra, E
    Martorana, P
    Banks, WA
    Peschon, JJ
    Schmidts, HL
    Brody, AR
    Friedman, M
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (04) : 825 - 833
  • [46] Elevated circulating p75-TNF-receptor levels predict the occurrence and duration of neutropenia after chemotherapy in lymphoma patients
    Voog, E
    Salles, G
    Bienvenu, J
    Bastion, Y
    Warzocha, K
    NeidhardtBerard, EM
    Coiffier, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1007 - 1007
  • [47] IDENTIFICATION OF DIFFERENTIALLY GLYCOSYLATED FORMS OF THE SOLUBLE P75 TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR IN HUMAN URINE
    CORTI, A
    DAMBROSIO, F
    MARINO, M
    MERLI, S
    CASSANI, G
    EUROPEAN CYTOKINE NETWORK, 1995, 6 (01) : 29 - 35
  • [48] Persistent elevation of circulating soluble TNF receptor (p75) in bleomycin-induced pulmonary fibrosis in mice.
    Sato, J
    Nakamura, H
    Inage, M
    Saito, H
    Inoue, S
    Terashita, K
    Kato, S
    Tomoike, H
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A657 - A657
  • [49] Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: Implications for pathogenesis and therapy of autoimmune demyelination
    Kassiotis, G
    Kollias, G
    JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (04): : 427 - 434
  • [50] Blunted induction of hepatic CYP4A in TNF (p55-/-/p75-/-) double receptor knockout mice following clofibrate treatment
    Van Ess, PJ
    Poloyac, S
    Mattson, MP
    Blouin, RA
    PHARMACEUTICAL RESEARCH, 2002, 19 (05) : 709 - 713
12345